Depressive symptoms prescreening and postscreening among returning participants in an ovarian cancer early detection program

Cancer Nursing

Volumn 28, Issue 4, 2005, Pages 325-330

  Tiffen, Jennifer ^a   Sharp, Lisa ^b   O'Toole, Cheryl ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CES D; Depressive symptom; Ovarian cancer screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DEPRESSION; DISTRESS SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RATING SCALE; SELF REPORT;

EID: 23244454938     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-200507000-00015     Document Type: Article

References (31)

1. American Cancer Society. Cancer Facts and Figures, 2003. Atlanta, Ga: American Cancer Society; 2003.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
3. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998;105:493-499.
4. Suris-Swartz PJ, Schildkraut JM, Vine MF, Hertz-Picciotto I. Age at diagnosis and multiple primary cancers of the breast and ovary. Breast Cancer Res Treat. 1996;41:21-29.
5. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Lancet. 1994;343:692-695.
6. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet. 1998;62:676-689.
7. National Cancer Institute. Ovarian cancer: screening. Available at: http:// www.cancer.gov/templates/doc_pdq.aspx?version=healthprofessional& cdrid=6276. Accessed June 21, 2004.
8. National Institutes of Health (NIH). Consensus Development Panel on Ovarian Cancer. Ovarian cancer: screening, treatment, and follow-up. JAMA. 1995;273:491-497.
9. Robinson GE, Rosen BP, Bradley LN, et al. Psychological impact of screening for familial ovarian cancer: reactions to initial assessment. Gynecol Oncol. 1997;65:197-205.
10. Hensley ML, Robson ME, Kauff ND, et al. Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life. Gynecol Oncol. 2003;89:440-446.
11. Anderson MR, Peacock S, Nelson J, et al. Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. Gynecol Oncol. 2002;85:3-8.
12. Schwartz MD, Peshkin BN, Hughes C, Main D, Issacs C, Lerman C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol. 2002;20:514-520.
13. Trask PC, Paterson AG, Wang C, et al. Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning. Psychooncology. 2001;10:349-360.
14. Ritvo P, Robinson G, Irvine J, et al. Psychological adjustment to familial genetic risk assessment: differences in two longitudinal samples. Patient Educ Couns. 2000;40:163-172.
15. Ritvo P, Robinson G, Irvine J, et al. A longitudinal study of psychological adjustment to familial genetic risk assessment for ovarian cancer. Gynecol Oncol. 1999;74:331-337.
16. Schwartz MD, Lerman C, Miller SM, Daly M, Masny A. Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychol. 1995;14:232-235.
17. Wardle FJ, Collins W, Pernet AL, Whitehead MI, Bourne TH, Campbell S. Psychological impact of screening for familial ovarian cancer. J Natl Cancer Inst. 1993;85:653-657.
18. Schroevers MJ, Sanderman R, vanSonderen E, Ranchor AV. The evaluation of the centers for epidemiologic studies depression (CES-D) scale: depressed and positive affect in cancer patients and healthy reference subjects. Qual Life Res. 2000;9:1015-1029.
19. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
20. Cohen J. A power primer. Psychol Bull. 1992;112:155-159.
21. Spitzer RL, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 study. JAMA. 1995;274:1511-1517.
22. Desai HD, Jann MW. Major depression in women: a review of the literature. J Am Pharm Assoc. 2000;40:525-537.
23. Liu L, Deapen D, Bernstein L. Socioeconomic status can cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California. Cancer Causes Control. 1998;9:369-380.
24. Avis NE. Depression during menopausal transition. Psychol Women Q. 2003;27:91-100.
25. Choi MW. Menopause and mood: Are they connected? Female Patient. 2001;9:62-63.
26. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994;12:843-850.
27. McCaul KD, Branstetter AD, O'Donnell SM, Jacobson K, Quinlan KB. A descriptive study of breast cancer worry. J Behav Med. 1998;21:565-579.
28. Burns N, Grove SK. The Practice of Nursing Research: Conduct, Critique, & Utilization. 3rd ed. Philadelphia: WB Saunders; 1997.
29. Valente SM, Saunders JM. Diagnosis and treatment of major depression among people with cancer. Cancer Nurs. 1997;20:168-177.
30. McDonald MV, Passik SD, Dugan W, Rosenfeld B, Theobald DE, Edgerton S. Nurses' recognition of depression in their patients with cancer. Oncol Nurs Forum. 1999;26:593-599.
31. Fincannon JL. Analysis of psychiatric referrals and interventions in an oncology population. Oncol Nurs Forum. 1995;22:87-92.